AIDS and the Private Sector in Africa
As evidence of very high HIV infection rates among working-aged adults in sub-Saharan Africa accumulated in the late 1990s, concern mounted that employers, and in particular private companies participating in competitive export markets, would lose large numbers of skilled workers and face greatly increased labor costs. Among the CGHD’s earliest work on HIV/AIDS was a series of studies on the costs of HIV to private companies and government agencies in various African countries, including South Africa, Botswana, Zambia, Kenya, and Uganda. Most of this research pre-dated large-scale access to effective treatment for HIV/AIDS and examined the likely impact of the disease on employers and economies in the absence of treatment. It was conducted under a variety of funding mechanisms over nearly a decade, starting in 1999. Methods and results can be found in the publications and other documents posted on this page.
|Principal Investigator||Sydney Rosen|
|Bruce Larson, Rich Feeley, Matthew Fox, Donald Thea, Jonathon Simon, Bill Macleod, Patrick Connelly|
|Country(ies)||South Africa, Kenya, Uganda, Zambia, Botswana|
|Dates of Research||1999–2007|